Table 7.

Anti-neuronal and anti-glial autoantibody findings in group I

	Serum, pos	CSF, pos
Hu-IgG	0/35	0/40
Yo-IgG	0/35	0/40
Ri-IgG	0/35	0/40
CV2/CRMP5-IgG	0/33	0/39
Tr/DNER-IgG	0/35	0/40
Ma2/Ta (PNMA2)-IgG	0/35	0/40
Ma1-IgG	0/5	0/4
Amphiphysin-IgG	0/34	0/39
GAD65-IgG	1/35	1/40§
Zic4-IgG	0/15	0/5
SOX1-IgG	0/15	0/5
mGluR5-IgG	0/27	0/34
GlycinR-IgG	0/28	0/35
Dopamin-2-R-IgG	0/27	0/34
IgLON-5-IgG	0/2	0/2
Recoverin-IgG	0/11	0/1
NMDAR-IgG	1/40	0/39
GABA-B-R-IgG	0/36	0/39
AMPA1/2-R (GluA1/GluA2)-IgG	0/35	0/39
DPPX-IgG	0/34	0/38
LGI1-IgG	0/36	0/40
CASPR2-IgG	0/41	0/39
MOG-IgG	0/3	0/1
AQP4-IgG	0/31	0/36
Nicotinergic AChR-IgG	0/1	0/0
IFT cerebellum	6/40#	0/34#
IFT intestine	0/8	0/0
IFT peripheral nerve	0/8	0/0
"Sulfatide Abs"	0/1	0/0
"Ganglioside Abs"	0/7	0/0
GM1-IgG/IgM	0/6	0/0
GM2-IgG/IgM	0/1	0/0
GM3-IgG/IgM	0/1	0/0
GM4-IgG/IgM	0/1	0/0
GQ1b-IgG/IgM	0/6	0/0
GD1a-IgG/IgM	0/1	0/0
GD1b-IgG/IgM	0/5	0/0
GD1c-IgG/IgM	0/1	0/0
GT1a-IgG/IgM	0/1	0/0
GT1b-IgG/IgM	0/1	0/0
GT1c-IgG/IgM	0/1	0/0
IFT skeletal muscle	1/6	0/0
Titin-IgG	0/7	0/0
Sum	9/766	1/743

^#Antimyelin antibodies of unknown specificity. ^§Only weakly (equivocally) positive. , Abs antibodies, AMPA1/2-R α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, AQP4 aquaporin-4, CASPR2 contactin-associated protein-like 2, DNER Delta and Notch-like epidermal growth factor-related receptor, DPPX dipeptidyl-peptidase-like protein-6; GABA-B1/2-R G-protein coupled receptors B1/2 for gamma-aminobutyric acid, GAD65 glutamic acid decarboxylase 65, GluR5 metabotropic glutamate receptor 5, IgLON-5 IgLON family member 5, LG1 Leucine-rich, glioma inactivated protein 1, MOG myelin oligodendrocyte glycoprotein, NMDAR N-methyl-D-aspartate, nAChR nicotinergic (i.e. ganglionic) acetylcholine receptors, pos positive, SOX1 SRY-box transcription factor 1, Zic4 Zic family member 4